Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels.
Author: Berrill JW1, Sadlier M2, Hood K3, Green JT4.
Affiliation:
1Department of Gastroenterology, University Hospital Llandough, Cardiff, UK. Electronic address: jamesberrill1@doctors.org.uk. 2Department of Physiotherapy, University Hospital of Wales, Cardiff, UK. 3South East Wales Trials Unit, Cardiff University, Cardiff, UK. 4Department of Gastroenterology, University Hospital Llandough, Cardiff, UK.
Conference/Journal: J Crohns Colitis.
Date published: 2014 Feb 12
Other:
Pages: S1873-9946(14)00023-3 , Special Notes: doi: 10.1016/j.crohns.2014.01.018. , Word Count: 272
BACKGROUND AND AIMS:
Psychological interventions are used in patients with inflammatory bowel disease (IBD) but there is uncertainty about who the optimal target population is. Multi-convergent therapy (MCT) is a form of psychotherapy that combines mindfulness meditation with aspects of cognitive behavioural therapy and has been used in the management of irritable bowel syndrome (IBS). This study aimed to assess the feasibility and efficacy of MCT in the management of IBD patients with either functional abdominal symptoms or high perceived stress levels.
METHODS:
Sixty-six IBD patients in clinical remission with either IBS-type symptoms or high perceived stress levels were randomly allocated to a 16-week MCT course or waiting list control group. Patients were followed-up for one year with the Inflammatory Bowel Disease Questionnaire (IBDQ) as the primary outcome measurement.
RESULTS:
A higher mean IBDQ score was observed in the active group compared to controls at the 4-month assessment (167 vs. 156, p=0.081), but this was not statistically significant nor did it reached the predefined clinically significant difference of 20. In patients with IBS-type symptoms at baseline there was a significantly higher mean IBDQ score in the active group compared to controls (161 vs. 145, p=0.021). There was no difference between groups in relapse rate based on faecal calprotectin measurement.
CONCLUSIONS:
IBS-type symptoms in patients with IBD represent a potential therapeutic target to improve quality of life. This study suggests that MCT may be useful in the management of these symptoms but larger studies are required to confirm this.
CLINICAL TRIAL REGISTRATION NUMBER:
NCT01426568.
Copyright © 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
KEYWORDS:
Inflammatory bowel disease, Irritable bowel syndrome, Mindfulness, Psychotherapy
PMID: 24529603
BACK
